Page last updated: 2024-11-03

prochlorperazine and Hypoparathyroidism

prochlorperazine has been researched along with Hypoparathyroidism in 1 studies

Prochlorperazine: A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612)
prochlorperazine : A member of the class of phenothiazines that is 10H-phenothiazine having a chloro substituent at the 2-position and a 3-(4-methylpiperazin-1-yl)propyl group at the N-10 position.

Hypoparathyroidism: A condition caused by a deficiency of PARATHYROID HORMONE (or PTH). It is characterized by HYPOCALCEMIA and hyperphosphatemia. Hypocalcemia leads to TETANY. The acquired form is due to removal or injuries to the PARATHYROID GLANDS. The congenital form is due to mutations of genes, such as TBX1; (see DIGEORGE SYNDROME); CASR encoding CALCIUM-SENSING RECEPTOR; or PTH encoding parathyroid hormone.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schaaf, M1
Payne, CA1

Trials

1 trial available for prochlorperazine and Hypoparathyroidism

ArticleYear
Dystonic reactions to prochlorperazine in hypoparathyroidism.
    The New England journal of medicine, 1966, Nov-03, Volume: 275, Issue:18

    Topics: Adolescent; Adult; Child; Clinical Trials as Topic; Female; Humans; Hypoparathyroidism; Injections,

1966